(Ron Davis's) nanoneedle biosensor technology used in this study
Obviously this study has huge potential. First, there's developing a model for this illlness at the cellular level, getting white blood cells to show stress-based changes mirroring PEM experienced in patients. Then there's the finding that the problem is in the serum not the cells (wow) - and the work underway to find out what in the serum is the problem Because the study is so important, I'd love to know a bit more about what the change in impedance actually means in terms of what's happening to cells.Here's what I found out - more answers very welcome.
Basic impedance approaches go back decades, measuring the impedance of the broth that bacteria are cultured in: metabolising bacteria chuck out metabolites that tend to be charged molecules that conduct better than water, so impedance (electrical resistance) falls.
This still from the video (transcript, thanks!) shows the technology used here is
nanoneedle biosensors, which is a Stanford Genome Technology center
nanobiotechnology project.
It was apparently developed by bioengineer Rahim Esfandyarpour, with Ron Davis as the senior author on the
2013 paper announcing it. Here's what I understand of it:
Nanoneedle: basically a tiny rod with 2 electrodes that measures impedance. Cells and medium/serum accumulate on the nanoneedle (not sure how many, small number I think) and it's the impedance of that mix that's measured.
Biosensor: normally this means it's 'tuned' to detect impedance from a particular molecule which could even be an antibody. Here it might be a a specific metabolite or metabolites. OR maybe they've chose to measure impedance more generally.
Here's a bit more on the mechanism from
another 2013 paper
Cells captured on the surface of the nanoneedle tip results in a decrease in the impedance across the sensing electrodes. The basic mechanisms behind the electrical response of cells in solution under an applied alternating electrical field stems from modulation of the relative permittivity at the interface.
Unfortunately that doesn't mean a whole lot to me! Answers welcome.
I'd also be interested to know they cells are 'stressed' as it's the all-important step distinguishing mecfs cells from healthy ones (or healthy cells in mecfs serum from healthies).
I sent an email a few days ago to Janet and Ron asking for more info (thanks for providing that,
@Rose49). I'm know they are both very busy but will post here if I hear anything back.